Insulet Corporation (PODD)

Return on equity (ROE)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	418,300	420,900	395,300	234,000	206,300	120,000	62,900	600	4,600	16,800	34,600	44,600	17,400	-28,900	-29,900	9,500	6,800	28,868	18,068	5,068
Total stockholders’ equity	US$ in thousands	1,211,600	1,118,000	998,400	790,700	732,700	607,500	553,900	502,800	476,400	428,000	422,400	446,700	556,300	497,900	459,100	585,300	603,600	595,000	563,300	59,000
ROE		34.52%	37.65%	39.59%	29.59%	28.16%	19.75%	11.36%	0.12%	0.97%	3.93%	8.19%	9.98%	3.13%	-5.80%	-6.51%	1.62%	1.13%	4.85%	3.21%	8.59%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $418,300K ÷ $1,211,600K
= 34.52%

Insulet Corporation's return on equity (ROE) has demonstrated fluctuations over the years, but there is a clear increasing trend from March 31, 2023, onwards.

From March 31, 2023, where the ROE was at 0.12%, it saw a steady improvement in subsequent quarters, reaching 29.59% by March 31, 2024. The ROE continued to rise significantly to 39.59% by June 30, 2024, and leveled off slightly to 34.52% by December 31, 2024.

This improvement in ROE from 0.12% to 34.52% over the course of just two years indicates a positive trajectory in the company's ability to generate profit relative to shareholder equity. This suggests that Insulet Corporation has been efficiently utilizing its equity to generate returns for its shareholders. It is important for the company to sustain this upward trend in ROE to demonstrate continued profitability and efficient use of capital.